Mansoor M Amiji (Mansoor Amiji)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Topics

Hyaluronic Acid

Top Venues

Molecular pharmaceutics

Nanomedicine (London, England)

Nature reviews. Drug discovery

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitrios Bitounis, Eric Jacquinet, Maximillian A Rogers, Mansoor M Amiji
Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nature reviews. Drug discovery (2024)
Dimitrios Bitounis, Eric Jacquinet, Maximillian A Rogers, Mansoor M Amiji
Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nature reviews. Drug discovery 23 (4) (2024)
Dimitrios Bitounis, Eric Jacquinet, Maximillian A Rogers, Mansoor M Amiji
Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nature reviews. Drug discovery 23 (4) (2024)
Dimitrios Bitounis, Mansoor M Amiji
Lipid nanoparticles target haematopoietic stem cells. Nature nanotechnology (2024)
Dimitrios Bitounis, Eric Jacquinet, Maximillian A Rogers, Mansoor M Amiji
Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nature reviews. Drug discovery 23 (4) (2024)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Andy Jian Kai Chua, Valentina Di Francesco, Di Huang, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Nanotechnology-enabled topical delivery of therapeutics in chronic rhinosinusitis. Nanomedicine (London, England) (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Anisha D'Souza, Saeideh Nozohouri, Benjamin S Bleier, Mansoor M Amiji
CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting. Pharmaceutical research (2022)
Srujan K Gandham, Husain Z Attarwala, Mansoor M Amiji
Mathematical Modeling and Experimental Validation of Extracellular Vesicle-Mediated Tumor Suppressor MicroRNA Delivery and Propagation in Ovarian Cancer Cells. Molecular pharmaceutics 19 (11) (2022)
Neha N Parayath, Srujan K Gandham, Mansoor M Amiji
Tumor-targeted miRNA nanomedicine for overcoming challenges in immunity and therapeutic resistance. Nanomedicine (London, England) 17 (19) (2022)
Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Role of 3D Printing in the Development of Biodegradable Implants for Central Nervous System Drug Delivery. Molecular pharmaceutics 19 (12) (2022)
Sevde Altuntaş, Harkiranpreet Kaur Dhaliwal, Ahmed Eid Radwan, Mansoor M Amiji, Fatih Buyukserin
Local epidermal growth factor delivery using nanopillared chitosan-gelatin films for melanogenesis and wound healing. Biomaterials science (2022)
Kevin Craig, Marc Abrams, Mansoor M Amiji
Cholesterol-Conjugated Short-Interfering RNA Silencing Tnf for the Treatment of Liver Macrophage-Mediated Acute Inflammation in Nonalcoholic Fatty Liver Disease. Nucleic acid therapeutics (2022)
Husain Z Attarwala, Kanika Suri, Mansoor M Amiji
Co-Silencing of Tissue Transglutaminase-2 and Interleukin-15 Genes in a Celiac Disease Mimetic Mouse Model Using a Nanoparticle-in-Microsphere Oral System. Molecular pharmaceutics 18 (8) (2021)
Neha N Parayath, Brian V Hong, Gerardo G Mackenzie, Mansoor M Amiji
Hyaluronic acid nanoparticle-encapsulated microRNA-125b repolarizes tumor-associated macrophages in pancreatic cancer. Nanomedicine (London, England) 16 (25) (2021)
Anisha A D'Souza, Shallu Kutlehria, Di Huang, Benjamin S Bleier, Mansoor M Amiji
Nasal delivery of nanotherapeutics for CNS diseases: challenges and opportunities. Nanomedicine (London, England) (2021)
Dongyu Chen, Shanthi Ganesh, Weimin Wang, Adrien Lupieri, Mansoor M Amiji
Role of vitronectin-rich protein corona on tumor-specific siRNA delivery and transfection with lipid nanoparticles. Nanomedicine (London, England) 16 (7) (2021)
Harkiranpreet Kaur Dhaliwal, Yingfang Fan, Jonghan Kim, Mansoor M Amiji
Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes. Molecular pharmaceutics 17 (6) (2020)
Ekta Kadakia, Pratiksha Harpude, Neha Parayath, Dean Bottino, Mansoor M Amiji
Challenging the CNS Targeting Potential of Systemically Administered Nanoemulsion Delivery Systems: a Case Study with Rapamycin-Containing Fish Oil Nanoemulsions in Mice. Pharmaceutical research 36 (9) (2019)
Gulzar Ahmad, Gerardo G Mackenzie, James Egan, Mansoor M Amiji
DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model. Molecular cancer therapeutics 18 (11) (2019)
Dongyu Chen, Neha N Parayath, Shanthi Ganesh, Weimin Wang, Mansoor M Amiji
The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for in vivo targeted delivery and transfection of oligonucleotides in murine tumor models. Nanoscale 11 (40) (2019)
Ekta Kadakia, Dean Bottino, Mansoor M Amiji
Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration. Pharmaceutical research 36 (5) (2019)
Neha N Parayath, Avani Parikh, Mansoor M Amiji
Repolarization of Tumor-Associated Macrophages in a Genetically Engineered Nonsmall Cell Lung Cancer Model by Intraperitoneal Administration of Hyaluronic Acid-Based Nanoparticles Encapsulating MicroRNA-125b. Nano letters 18 (6) (2018)
Hibah M Aldawsari, Harkiranpreet Kaur Dhaliwal, Bader Mubarak Aljaeid, Nabil A Alhakamy, Zainy Mohammad Banjar, Mansoor M Amiji
Optimization of the Conditions for Plasmid DNA Delivery and Transfection with Self-Assembled Hyaluronic Acid-Based Nanoparticles. Molecular pharmaceutics 16 (1) (2018)
Grishma N Pawar, Neha N Parayath, Angela L Nocera, Benjamin S Bleier, Mansoor M Amiji
Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting. PloS one 13 (12) (2018)
Sunita Yadav, Grishma Pawar, Praveen Kulkarni, Craig Ferris, Mansoor M Amiji
CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations. The Journal of pharmacology and experimental therapeutics 370 (3) (2018)
Husain Attarwala, Valerie Clausen, Prasoon Chaturvedi, Mansoor M Amiji
Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease. Molecular pharmaceutics 14 (9) (2017)